SCHEMBL28691066

SCHEMBL28691066

COc1ccc(-c2cnc(NC(=O)c3cc(-c4ccccc4)nc4ccccc34)[nH]2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 4/20 0.68
▸ MEN1 O00255 5/20 0.60
▸ KMT2A Q03164 5/20 0.60
▸ RAB9A P51151 4/20 0.60
▸ NPC1 O15118 3/20 0.60
▸ RUVBL1 Q9Y265 1/20 0.59
▸ KLK7 P49862 1/20 0.59
▸ TACR3 P29371 3/20 0.59
▸ KDM4E B2RXH2 4/20 0.56
▸ ALDH1A1 P00352 2/20 0.56
▸ CNR1 P21554 1/20 0.56
▸ POLB P06746 1/20 0.55
▸ SMN1; SMN2 Q16637 2/20 0.55
▸ MAPT P10636 2/20 0.55
▸ TDP1 Q9NUW8 2/20 0.55
▸ ALOX12 P18054 1/20 0.55
▸ HTT P42858 1/20 0.55
▸ LMNA P02545 1/20 0.54
▸ HPGD P15428 1/20 0.54
▸ NFKB1 P19838 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28673422 0.89 MEN1 (0.59) CYP3A4MEN1KMT2ARAB9ANPC1
SCHEMBL28691056 0.88 PLA2G2A (0.53) CYP3A4MEN1KMT2ARAB9ANPC1
SCHEMBL28931959 0.87 STAT3 (0.59) CYP3A4MEN1KMT2ATACR3KDM4E
SCHEMBL28699070 0.84 MAPT (0.57) CYP3A4MEN1KMT2AKDM4EALDH1A1
SCHEMBL28672666 0.83 CYP2C9 (0.68) CYP3A4MEN1KMT2AKDM4EALDH1A1
SCHEMBL28931754 0.82 MEN1 (0.59) CYP3A4MEN1KMT2AKDM4EALDH1A1
SCHEMBL28690150 0.82 STAT3 (0.61) CYP3A4MEN1KMT2ATACR3KDM4E
SCHEMBL28696167 0.81 MCL1 (0.55) CYP3A4MEN1KMT2ATACR3TDP1
SCHEMBL28681436 0.80 STAT3 (0.61) CYP3A4MEN1KMT2AKDM4EALDH1A1
SCHEMBL28680454 0.78 TP53 (0.55) CYP3A4MEN1KMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113747920-A Immune checkpoint inhibitor combination therapy using quinoline carboxamide derivatives 株式会社益力多本社 2021-12-03 — — CN disclosed
CN-112703001-A Combination cancer therapy using quinoline carboxamide derivatives 株式会社益力多本社 2021-04-23 — — CN disclosed
Send feedback